Awm Investment Company, Inc. Cytosorbents Corp Transaction History

Awm Investment Company, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.55 - $9.42 $1.13 Million - $1.41 Million	-150,000 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$8.23 - $11.48 $411,500 - $574,000	-50,000 Reduced 25.0%	150,000 $1.3 Million
Q4 2020 Feb 12, 2021	BUY	$7.65 - $8.98 $1.53 Million - $1.8 Million	200,000 New	200,000 $1.59 Million

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Awm Investment Company, Inc. with notifications on news.